Benzinga - Gainers
- EUDA Health Holdings Limited (NASDAQ: EUDA) shares rose 88.1% to $8.40 in pre-market trading after merger completed with 8i Acquisition SPAC last week.
- Meta Materials Inc. (NASDAQ: MMAT) shares rose 26.5% to $2.10 in pre-market trading after dropping around 7% on Friday.
- Assure Holdings Corp. (NASDAQ: IONM) rose 21.4% to $0.5585 in pre-market trading. The company, last week, posted downbeat quarterly results.
- Cosmos Holdings Inc. (NASDAQ: COSM) rose 19.6% to $0.1729 in pre-market trading after jumping over 10% on Friday.
- WeTrade Group, Inc. (NASDAQ: WETG) rose 16.4% to $1.35 in pre-market trading after the company reported a $120 million agreement with Vmade Tech PTE. LTD for launching operation of WTPay Technology Tools in Singapore.
- Excellon Resources Inc. (NYSE: EXN) rose 16.4% to $0.4248 in pre-market trading after dropping 2% on Friday.
- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) rose 16.2% to $0.1278 in pre-market trading after declining around 10% on Friday.
- Sotera Health Company (NASDAQ: SHC) rose 15.6% to $6.96 in pre-market trading. Barclays (LON:BARC), last week, downgraded Sotera Health from Equal-Weight to Underweight and lowered the price target from $7 to $6.
- Helbiz, Inc. (NASDAQ: HLBZ) shares jumped 12.5% to $0.20 in pre-market trading. Helbiz recently posted a Q3 loss of $0.45 per share.
- NextPlay Technologies, Inc. (NASDAQ: NXTP) rose 11.7% to $0.22 in pre-market trading. NextPlay Technologies, last month, announced its NextFintech division received commitment for a $15 million strategic investment.
- The9 Limited (NASDAQ: NCTY) rose 10.1% to $0.81 in pre-market trading. The9 is scheduled to hold its annual general meeting on December 19, 2022.
- Blue Apron Holdings, Inc. (NYSE: APRN) rose 8.9% to $1.22 in pre-market trading.
- Plus Therapeutics, Inc. (NASDAQ: PSTV) rose 8.5% to $0.4992 in pre-market trading. Plus Therapeutics, last month, posted a Q3 loss of $0.19 per share.
- Beyond Air, Inc (NASDAQ: XAIR) rose 8.4% to $6.30 in pre-market trading. Beyond Air recently posted a Q2 loss of $0.40 per share.
- The Walt Disney Company (NYSE: NYSE:DIS) rose 8.1% to $99.20 in pre-market trading. Disney said Robert A. Iger is returning to lead the company as Chief Executive Officer, effective immediately.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or
remove ads
.
Losers
- G Medical Innovations Holdings Ltd (NASDAQ: GMVD) shares fell 35.1% to $3.41 in pre-market trading after the company reported first half 2022 financial results and issued a business update.
- Heliogen, Inc. (NYSE: HLGN) fell 20% to $0.80 in pre-market trading. Heliogen recently posted a Q3 loss of $0.14 per share.
- Iveda Solutions, Inc. (NASDAQ: IVDA) shares fell 13% to $0.6028 in pre-market trading.
- Sunshine Biopharma, Inc. (NASDAQ: SBFM) fell 12.3% to $0.8510 in pre-market trading. Sunshine Biopharma recently entered into a collaboration agreement with a North American lipid nanoparticle (LNP) company to advance the development of its mRNA-based anticancer macromolecule, K1.1.
- Grindr Inc. (NYSE: GRND) shares fell 12.2% to $32.00 in pre-market trading. Grindr shares jumped around 214% on Friday after the stock began trading following the completion of its combination with Tiga Acquisition Corp.
- Kaspien Holdings Inc. (NASDAQ: KSPN) fell 11.2% to $0.7637 in pre-market trading.
- Lizhi Inc. (NASDAQ: LIZI) shares fell 9.6% to $0.6330 in pre-market trading. The company recently posted a profit for the third quarter.
- Gritstone bio, Inc. (NASDAQ: GRTS) fell 9.5% to $3.00 in pre-market trading. Gritstone bio recently announced updated overall survival (OS) results from its Phase 1/2 study evaluating GRANITE, an individualized vaccine-based immunotherapy for advanced solid tumors.
- Alset Inc. (NASDAQ: AEI) fell 8.1% to $0.16 in pre-market trading after gaining around 9% on Friday.
- Mobilicom Limited (NASDAQ: MOB) fell 7.7% to $1.32 in pre-market trading. Mobilicom, last month, announced its SkyHopper COMBO was selected by the Israeli Ministry of Defense for a new fleet deployment program.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or
remove ads
.
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.